Jona
Jona is a New York-based digital health company that uses shotgun metagenomic sequencing and AI, trained on 220,000+ studies, to deliver personalized gut microbiome insights and diet, supplement, and lifestyle recommendations to U.S. consumers and healthcare practitioners.
- Company typePrivate
- Founded2023
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Jona does
Jona (Jona, Inc.) is a New York-based digital health company that sells an at-home gut microbiome test built on deep shotgun metagenomic sequencing, which identifies microorganisms including bacteria, viruses, fungi, parasites, and archaea at strain-level resolution. The raw sequencing output is processed by an AI interpretation engine trained on over 220,000 peer-reviewed studies, which generates personalized diet, supplement, and lifestyle recommendations across GI, skin, metabolic, brain, and physical performance categories. The company's stated reach is 1.2 million microbiome insights delivered to date.
Jona operates a hybrid go-to-market model. Direct-to-consumer is the primary motion, with the test sold through jona.health at $485 (FSA/HSA eligible, free shipping). Distribution is being extended through a March 2026 partnership with Everlywell — the leading U.S. at-home lab testing platform — where the test is offered at $399. A separate practitioner channel targets dietitians, gastroenterologists, and health coaches through a dedicated sales/scheduling flow; this channel was materially expanded through a May 2026 partnership with Microbiome Labs to relaunch the BiomeFX Functional Microbiome Analysis service.
The company was founded around 2022-2023, raised $5 million in seed funding in November 2023 (led by Breyer Capital and Meridian Street Capital, with Alumni Ventures), and remains privately held with a 1-10 person team. Operations are U.S.-only, the company holds no disclosed patents, and revenue is not publicly reported. Founder and CEO Leo Grady (formerly of Paige.AI) leads the company alongside Chief Commercial Officer & COO Chao Wang.
Jona firmographics
Firmographics- Name
- Jona
- Legal name
- Jona, Inc.
- Website
- https://jona.health
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Jona is a New York-based digital health company that uses shotgun metagenomic sequencing and AI, trained on 220,000+ studies, to deliver personalized gut microbiome insights and diet, supplement, and lifestyle recommendations to U.S. consumers and healthcare practitioners.
- Ownership category
- akta.pro rank
Jona industry classification
Industry- Product category
- Microbiome Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
- akta.pro secondary industries
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH), Microbiome & Metagenomics Services (HLAGANAH)
Keywords
Where Jona is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Jona business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure, Supply Chain
Revenue model
- Direct-to-Consumer Microbiome Testing: Jona sells its microbiome analysis test directly to consumers through its e-commerce platform at $485 per test, with the test being FSA/HSA eligible. The company also distributes through partnerships with platforms like Everlywell where the test is offered at $399.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard Microbiome Test |
| Unit Pricing | Pay-as-you-go | Everlywell Partnership Price |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Jona product offering
Product offeringCore offering
Jona sells an at-home gut microbiome test kit and accompanying AI-generated health report. Customers collect a stool sample, the company performs deep shotgun metagenomic sequencing to identify 170,000+ microorganisms, and an AI engine trained on 220,000+ peer-reviewed studies produces personalized diet, supplement, and lifestyle recommendations linked to GI, skin, metabolic, brain, and physical performance health associations. The test is offered direct-to-consumer for $485 and through an Everlywell partnership for $399, with a separate clinical channel for healthcare practitioners.
Product overview
Jona offers a unified AI-powered gut microbiome analysis platform consisting of a direct-to-consumer at-home test kit (Jona Microbiome Analysis), a practitioner-facing clinical solution (Jona for Practitioners), and educational content (Jona Journal). The core product uses shotgun metagenomic sequencing to identify microorganisms and AI to generate personalized diet, supplement, and lifestyle recommendations. The practitioner module extends the platform with advanced biomarker panels for clinical use. The company has delivered over 1.2 million microbiome insights and partners with Everlywell for nationwide distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- Jona Microbiome Analysis AI-powered at-home gut microbiome test using shotgun metagenomic sequencing to identify 170,000+ microorganisms including bacteria, viruses, fungi, and parasites. Delivers personalized diet, supplement, and lifestyle recommendations based on individual microbiome profiles. Sold direct to consumers for $485 and via Everlywell for $399; FSA/HSA eligible.
- Jona for Practitioners
Quantifiable outcome
- 1.2 million microbiome insights delivered
- +2 more outcomes
Companies that use Jona
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Jona technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature3 records
Jona partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Microbiome LabscoreMicrobiome Labs relaunched its BiomeFX Functional Microbiome Analysis in partnership with Jona. The service features Jona's AI-powered interpretation layer trained on over 220,000 peer-reviewed studies, using shotgun metagenomic sequencing for strain-level resolution and functional pathway insights. Industry implications suggest potential disruption to clinical diagnostics, nutritional supplementation, and digital health platforms through evidence-based, microbiome-tailored solutions.
- EverlywellcoreJona partnered with Everlywell, the leading U.S. at-home lab testing company, to distribute its AI-powered gut microbiome test nationwide on Everlywell's digital health platform. The test uses deep shotgun metagenomic sequencing and AI to analyze gut microbiome health. The partnership aims to expand access to microbiome testing, with the test offered at $399 on Everlywell compared to Jona's typical price of $485. Everlywell noted that 60 to 70 million Americans are affected by digestive diseases, representing a significant market opportunity.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Jona competitors and assessment
Company assessmentDirect peers
- Zoe: Consumer gut-microbiome and metabolic health testing with personalized nutrition scoring, a direct competitor in the premium AI-personalized microbiome category.
- Seed Health: Microbiome-focused consumer brand combining at-home testing with a proprietary synbiotic supplement line, competing in the same microbiome-personalization category as Jona.
- Viome: Direct competitor in DTC AI-driven gut microbiome testing with metatranscriptomic sequencing and personalized nutrition recommendations. Closely comparable product, business model, and target consumer.
- Thorne: Offers the OneGut microbiome test alongside supplements and personalized recommendations, directly overlapping Jona's gut-health, supplement, and lifestyle positioning.
- DayTwo: Provides AI-driven gut-microbiome analysis with personalized nutrition recommendations for glycemic and metabolic health, directly comparable in product and AI methodology.
Broad incumbents
- Quest Diagnostics: Large clinical diagnostics provider offering a growing menu of microbiome and gut-health panels; broad incumbent with overlapping diagnostic testing capability that could enter or expand in Jona's category.
Emerging players
- Thryve: Gut microbiome testing and personalized probiotic/probiotic-food recommendations for consumers and brands, adjacent competitor in personalized microbiome-driven wellness.
- Atlas Biomed: DNA and microbiome-based personal health testing with AI-driven recommendations, partial overlap with Jona's gut microbiome analysis and personalized wellness focus.
- Sun Genomics: Custom probiotic and gut-microbiome testing company with personalized supplement formulations, comparable on microbiome testing + supplement recommendation model.
- Floré: DTC gut microbiome testing company offering personalized probiotics, overlapping with Jona's testing-plus-recommendation offering at the consumer end.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Jona social profiles
Digital presenceJona financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jona leadership team
Management profileNumber of profiles
Profiles2 records
Jona funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jona M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jona
What does Jona do?
Jona sells an at-home gut microbiome test kit and accompanying AI-generated health report. Customers collect a stool sample, the company performs deep shotgun metagenomic sequencing to identify 170,000+ microorganisms, and an AI engine trained on 220,000+ peer-reviewed studies produces personalized diet, supplement, and lifestyle recommendations linked to GI, skin, metabolic, brain, and physical performance health associations. The test is offered direct-to-consumer for $485 and through an Everlywell partnership for $399, with a separate clinical channel for healthcare practitioners.
Is Jona a public or private company?
Jona is a private company. It is classified as venture growth investor backed and is currently operating.
When was Jona founded?
Jona was founded in 2023. It employs 1 to 10 people.
Where is Jona based?
Jona is headquartered in New York, United States, in the North America region.
How does Jona make money?
One revenue line is on record: direct-to-Consumer Microbiome Testing.
Who are Jona's main competitors?
Direct peers on record are Zoe, Seed Health, Viome, Thorne and DayTwo. Quest Diagnostics is listed as a broad incumbent. Emerging players are Thryve, Atlas Biomed, Sun Genomics and Floré.
Does Jona have an API?
No public API is recorded for Jona.
What industry is Jona in?
Jona's product category is Microbiome Testing Services. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal). Its NAICS code is 621511 and its SIC code is 8071.